CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | Ali Asif Chief Financial Officer | Sale | −2,248 | $32.33 | $73K | 38,397 |
| 2024-03-01 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) | −12,000 | 51,750 | ||
| 2024-02-29 | Ali Asif Chief Financial Officer | Sale | −7,850 | $30.61 | $240K | 42,734 |
| 2024-02-29 | Ali Asif Chief Financial Officer | Sale | −2,089 | $31.00 | $65K | 40,645 |
| 2024-02-26 | PATEL DINESH V PH D President and CEO | Shares withheld for taxes | −10,915 | $29.53 | $322K | 604,590 |
| 2024-02-26 | Gupta Suneel Chief Development Officer | Shares withheld for taxes | −4,282 | $29.53 | $126K | 183,285 |
| 2024-02-15 | PATEL DINESH V PH D President and CEO | Shares withheld for taxes | −3,717 | $28.23 | $105K | 615,505 |
| 2024-01-16 | MOLINA ARTURO MD Chief Medical Officer | Shares withheld for taxes | −427 | $24.63 | $11K | 48,350 |
| 2024-01-16 | Ali Asif Chief Financial Officer | Shares withheld for taxes | −1,452 | $24.63 | $36K | 50,584 |
| 2024-01-09 | Gupta Suneel Chief Development Officer | Option exercise 10b5-1 | +5,000 | $7.38 | $37K | 192,567 |
| 2024-01-09 | Gupta Suneel Chief Development Officer | Sale 10b5-1 | −5,000 | $25.00 | $125K | 187,567 |
| 2024-01-09 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 45,000 | ||
| 2024-01-02 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +25,700 | 25,700 | ||
| 2024-01-02 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +25,700 | 25,700 | ||
| 2024-01-02 | Gupta Suneel Chief Development Officer | Grant or award | +19,250 | 187,567 | ||
| 2024-01-02 | Gupta Suneel Chief Development Officer | Grant or award · Stock Option (right to buy) | +71,500 | 71,500 | ||
| 2024-01-02 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +25,700 | 25,700 | ||
| 2024-01-02 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +25,700 | 25,700 | ||
| 2024-01-02 | PATEL DINESH V PH D President and CEO | Grant or award | +84,875 | 619,222 | ||
| 2024-01-02 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +315,250 | 315,250 |
Page 13 of 29 · 580 trades